From: Solubility enhancing lipid-based vehicles for artemether and lumefantrine destined for the possible treatment of induced malaria and inflammation: in vitro and in vivo evaluations
Groups
Antimalarial activity (%)
Group A
56.36
Group B
43.05
Group C
72.63
Group D
77.07
Group E
84.23
Group F
85.21
Group G
55.03
Group H
–
Group I
Group J
Group K
15.18
Group L
20.12
Group M
Group N
Group P
21.20